Evolus (EOLS) Retained Earnings (2017 - 2026)
Evolus (EOLS) reported Retained Earnings of -$278000.0 for Q1 2026, up 99.96% on a YoY basis from -$139030.8 in Q1 2025, and up 99.96% quarter-over-quarter from -$661.0 million in Q4 2025.
Evolus (EOLS) Retained Earnings (2017 - 2026) Analysis & Trends
Evolus has reported Retained Earnings for 10 years, with the latest figure at -$278000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.96% year-over-year to -$278000.0; the trailing twelve-month figure through Mar 2026 stood at -$278000.0 (up 99.96% YoY), and the FY2025 full-year result was -$661.0 million, down 8.47% from the prior year.
- Retained Earnings for Q1 2026 stood at -$278000.0, up from -$661.0 million in the prior quarter.
- The five-year high for Retained Earnings was -$137000.0 in Q3 2025, with the low at -$661.0 million in Q4 2025.
- Historically, Retained Earnings has averaged -$264.0 million across 5 years, with a median of -$689000.0 in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 99.96% — and 2023, when it plunged 321248.48%.
- Evolus' Retained Earnings stood at -$337000.0 in 2022, then tumbled by 165769.14% to -$559.0 million in 2023, then declined by 9.02% to -$609.4 million in 2024, then slipped by 8.47% to -$661.0 million in 2025, then soared by 99.96% to -$278000.0 in 2026.
- The last three Retained Earnings figures came in at -$278000.0 (Q1 2026), -$661.0 million (Q4 2025), and -$137000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | -278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278,000.00 |
| Dec 31, 2025 | -661.04 Mn |
| Sep 30, 2025 | -137,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | -628.29 Mn |
| Dec 31, 2024 | -609.40 Mn |
| Sep 30, 2024 | -689,000.00 |
| Jun 30, 2024 | -601,000.00 |
| Mar 31, 2024 | -572.09 Mn |
| Dec 31, 2023 | -558.98 Mn |
| Sep 30, 2023 | -606,000.00 |
| Jun 30, 2023 | -530.23 Mn |
| Mar 31, 2023 | -416,000.00 |
| Dec 31, 2022 | -337,000.00 |
| Sep 30, 2022 | -484.13 Mn |
| Jun 30, 2022 | -165,000.00 |
| Mar 31, 2022 | -440.38 Mn |
| Dec 31, 2021 | -422.88 Mn |
| Sep 30, 2021 | -404.71 Mn |
| Jun 30, 2021 | -385.27 Mn |